Literature DB >> 24164356

Diagnostic and prognostic value of MRI T2 quantification in heart transplant patients.

Laurent Bonnemains1, Thibaut Villemin, Jean-Marie Escanye, Gabriela Hossu, Freddy Odille, Fabrice Vanhuyse, Jacques Felblinger, Pierre-Yves Marie.   

Abstract

This study was designed retrospectively to assess the value of myocardial T2 to detect or predict ongoing acute heart rejection, in heart transplant patients, with a 1.5-T MRI magnet. One hundred and ninety-six myocardial T2 quantifications were performed on sixty consecutive heart transplant patients during routine follow-up. T2 values were assessed (i) with regard to the results of concomitant biopsies and (ii) with a Cox multivariate model for the prediction of subsequent rejections, defined by a ≥ grade 2 at biopsy or highly suspected in the absence of biopsy (>10% drop in ejection fraction with subsequent reversibility under treatment). T2 values were proposed as main covariate, after logit transformation and adjustment for other confounding parameters such as delay since graft surgery and delay before biopsy. T2 values were strongly linked (i) to the presence of rejection on concomitant biopsy (P < 0.0001) and (ii) to the risk of subsequent rejection on Cox multivariate model (P < 0.001). T2 values above 60 ms were associated with relative risk of rejection higher than 2.0 and rapidly increasing. In conclusion, myocardial T2 yields a high diagnostic and prognostic value for graft rejection in heart transplant patients.
© 2013 Steunstichting ESOT. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  MRI; T2 quantification; heart graft rejection; prognostic

Mesh:

Year:  2013        PMID: 24164356     DOI: 10.1111/tri.12222

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

1.  Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation.

Authors:  Ryan S Dolan; Amir A Rahsepar; Julie Blaisdell; Kenichiro Suwa; Kambiz Ghafourian; Jane E Wilcox; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Allen S Anderson; Clyde W Yancy; Jeremy D Collins; James C Carr; Michael Markl
Journal:  JACC Cardiovasc Imaging       Date:  2019-03-13

2.  Donor and Recipient Characteristics in Heart Transplantation Are Associated with Altered Myocardial Tissue Structure and Cardiac Function.

Authors:  Ryan S Dolan; Amir A Rahsepar; Julie Blaisdell; Roberto Sarnari; Kambiz Ghafourian; Jane E Wilcox; Sadiya S Khan; Esther E Vorovich; Jonathan D Rich; Clyde W Yancy; Allen S Anderson; James C Carr; Michael Markl
Journal:  Radiol Cardiothorac Imaging       Date:  2019-12-19

3.  Design of the DRAGET Study: a multicentre controlled diagnostic study to assess the detection of acute rejection in patients with heart transplant by means of T2 quantification with MRI in comparison to myocardial biopsies.

Authors:  Laurent Bonnemains; Aboubaker Cherifi; Nicolas Girerd; Freddy Odille; Jacques Felblinger
Journal:  BMJ Open       Date:  2015-10-29       Impact factor: 2.692

4.  Cardiovascular magnetic resonance in heart transplant patients: diagnostic value of quantitative tissue markers: T2 mapping and extracellular volume fraction, for acute rejection diagnosis.

Authors:  Emmanuelle Vermes; Clémence Pantaléon; Adrien Auvet; Nicolas Cazeneuve; Marie Christine Machet; Anne Delhommais; Thierry Bourguignon; Michel Aupart; Laurent Brunereau
Journal:  J Cardiovasc Magn Reson       Date:  2018-08-27       Impact factor: 5.364

5.  Multi-parametric cardiovascular magnetic resonance with regadenoson stress perfusion is safe following pediatric heart transplantation and identifies history of rejection and cardiac allograft vasculopathy.

Authors:  Nazia Husain; Kae Watanabe; Haben Berhane; Aditi Gupta; Michael Markl; Cynthia K Rigsby; Joshua D Robinson
Journal:  J Cardiovasc Magn Reson       Date:  2021-11-22       Impact factor: 5.364

6.  Cardiovascular magnetic resonance native T2 and T2* quantitative values for cardiomyopathies and heart transplantations: a systematic review and meta-analysis.

Authors:  G J H Snel; M van den Boomen; L M Hernandez; C T Nguyen; D E Sosnovik; B K Velthuis; R H J A Slart; R J H Borra; N H J Prakken
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-11       Impact factor: 5.364

7.  Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation.

Authors:  Colin G Stirrat; Shirjel Alam; Thomas J MacGillivray; Calum Gray; Marc Richard Dweck; Victor Jones; William Wallace; John R Payne; Sanjay K Prasad; Roy S Gardner; Mark C Petrie; Saeed Mirsadraee; Peter Henriksen; David E Newby; Scott Semple
Journal:  Open Heart       Date:  2019-10-03

Review 8.  Cardiovascular Magnetic Resonance Imaging and Heart Failure.

Authors:  Chuanfen Liu; Victor A Ferrari; Yuchi Han
Journal:  Curr Cardiol Rep       Date:  2021-03-08       Impact factor: 2.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.